Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Amgen

Amgen’s Xgeva delays prostate cancer bone pain

A clinical trial of Amgen Inc’s bone drug, Xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain—a finding the company believes will help boost the drug’s market potential.

Amgen said in December that monthly injections of Xgeva, also known as denosumab, added 4.2 months, compared… Amgen’s Xgeva delays prostate cancer bone pain   



anorectal canal1 - skeletal complication1 - heart damage1 - the journal of urology2 - pregnancy complications1 - risk of cancer1 - psa velocity screening1 - aua1 - vcug1 - prostate biopsy4 - radiographic imaging1 - childbirth2 - hypocitraturia1 - biomarkers1 - honey oil1 - hepatolenticular degeneration1 - routine antenatal sonography1 - renal replacement treatment1 - cervical cancer1 - end-stage renal failure1 - percutaneous nephrolithotomy1 - etoposide-doxorubicin-cisplatin1 - local anesthesia1 - genetic disease1 - robot-assisted partial nephrectomy1 - busm1 - burning2 - journal of urology5 - thiazides1 - urinary tract dysfunction1 -